1. Home
  2. DRTS vs IRMD Comparison

DRTS vs IRMD Comparison

Compare DRTS & IRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Alpha Tau Medical Ltd.

DRTS

Alpha Tau Medical Ltd.

HOLD

Current Price

$13.15

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Logo iRadimed Corporation

IRMD

iRadimed Corporation

HOLD

Current Price

$92.02

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DRTS
IRMD
Founded
2015
1992
Country
Israel
United States
Employees
121
166
Industry
Medical/Dental Instruments
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.0B
1.2B
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
DRTS
IRMD
Price
$13.15
$92.02
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$8.67
$116.00
AVG Volume (30 Days)
553.0K
109.3K
Earning Date
05-18-2026
05-01-2026
Dividend Yield
N/A
0.95%
EPS Growth
N/A
16.67
EPS
N/A
0.86
Revenue
N/A
$83,814,000.00
Revenue This Year
N/A
$12.38
Revenue Next Year
$699.98
$11.31
P/E Ratio
N/A
$106.06
Revenue Growth
N/A
14.43
52 Week Low
$3.01
$67.84
52 Week High
$14.11
$107.90

Technical Indicators

Market Signals
Indicator
DRTS
IRMD
Relative Strength Index (RSI) 57.08 42.18
Support Level $11.24 $90.96
Resistance Level $14.00 $97.63
Average True Range (ATR) 0.80 3.10
MACD -0.02 -0.50
Stochastic Oscillator 69.05 18.99

Price Performance

Historical Comparison
DRTS
IRMD

About DRTS Alpha Tau Medical Ltd.

Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.

About IRMD iRadimed Corporation

iRadimed Corp develops, manufactures, markets, and distributes a Magnetic Resonance Imaging (MRI) compatible intravenous (IV) infusion pump system, and MRI compatible patient vital signs monitoring system, and accessories and services relating to them. The company provides a non-magnetic IV infusion pump system, which is designed to be safe for use during MRI procedures. The MRI products of the company are sold to hospitals and acute care facilities in the United States and internationally. It generates the majority revenue from United States.

Share on Social Networks: